Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1264

    1.

    Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

    Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH.

    Ann Intern Med. 2005 Nov 1;143(9):621-31.PMID: 16263884 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Relapse and treatment resistance in patients with small-vessel vasculitis.

    [No authors listed]

    Ann Intern Med. 2005 Nov 1;143(9):I22. No abstract available. PMID: 16263880 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.

    Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA.

    Rheumatology (Oxford). 2006 Jun;45(6):724-9. Epub 2006 Jan 6.PMID: 16399845 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.

    Slot MC, Tervaert JW, Boomsma MM, Stegeman CA.

    Arthritis Rheum. 2004 Apr 15;51(2):269-73.PMID: 15077271 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts.

    Pagnoux C, Hogan SL, Chin H, Jennette JC, Falk RJ, Guillevin L, Nachman PH.

    Arthritis Rheum. 2008 Sep;58(9):2908-18.PMID: 18759282 [PubMed - in process]Related articlesFree article

    6.

    Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

    Nachman PH, Hogan SL, Jennette JC, Falk RJ.

    J Am Soc Nephrol. 1996 Jan;7(1):33-9.PMID: 8808107 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.

    Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears AK, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U; WGET Research Group.

    Ann Intern Med. 2007 Nov 6;147(9):611-9.PMID: 17975183 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.

    Stangou M, Asimaki A, Bamichas G, Christidou F, Zoumbaridis N, Natse T, Galanis N, Christaki P, Patakas D, Sombolos K.

    J Nephrol. 2005 Jan-Feb;18(1):35-44.PMID: 15772921 [PubMed - indexed for MEDLINE]Related articles

    9.

    Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

    De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR.

    Arthritis Rheum. 2005 Aug;52(8):2461-9.PMID: 16052573 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.

    Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.

    Nephrol Dial Transplant. 2008 Apr;23(4):1307-12. Epub 2007 Dec 8.PMID: 18065810 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

    de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO; EUVAS (European Vasculitis Study Group).

    Ann Intern Med. 2009 May 19;150(10):670-80.PMID: 19451574 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experience.

    Nakabayashi K, Arimura Y, Yoshihara K, Fukuoka T, Karube M, Yamato T, Koji H, Ikegaya N, Ohtuka T, Kawashima S, Sudo M, Yamada A.

    Mod Rheumatol. 2009;19(4):420-6. Epub 2009 Jun 12.PMID: 19521745 [PubMed - indexed for MEDLINE]Related articles

    13.

    ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.

    Harper L, Savage CO.

    Rheumatology (Oxford). 2005 Apr;44(4):495-501. Epub 2004 Dec 21.PMID: 15613403 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.

    Zhang X, Dong Y, Zeng X, Li Y, Tang F.

    Chin Med Sci J. 2002 Mar;17(1):32-5.PMID: 12894882 [PubMed - indexed for MEDLINE]Related articles

    15.

    Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis.

    Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT.

    Nephrol Dial Transplant. 2005 Jan;20(1):96-104. Epub 2004 Nov 16.PMID: 15546891 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    ANCA-associated vasculitis: diagnostic and therapeutic strategy.

    Ozaki S.

    Allergol Int. 2007 Jun;56(2):87-96. Epub 2007 May 1. Review.PMID: 17460438 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

    Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR; Pan-Thames Renal Research Group.

    Am J Kidney Dis. 2003 Apr;41(4):776-84. Review.PMID: 12666064 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

    Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ.

    J Am Soc Nephrol. 1996 Jan;7(1):23-32.PMID: 8808106 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis.

    Weidanz F, Day CJ, Hewins P, Savage CO, Harper L.

    Am J Kidney Dis. 2007 Jul;50(1):36-46.PMID: 17591523 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data